Medical Writing Market Size
The global medical writing market size was valued at $4.31 billion in 2025 and is projected to reach $8.06 billion by 2031, growing at a CAGR of 11.0% during the forecast period.
Medical Writing Market Overview
Medical writing is a specialized discipline focused on creating clear, accurate, and concise documents related to healthcare and medicine. This field encompasses a wide variety of materials, including regulatory documents, clinical trial reports, scientific research papers, and medical education content.
Companies can benefit significantly from medical writing by ensuring compliance with stringent regulatory requirements, which is crucial for drug approval and product labeling. High-quality medical writing facilitates effective communication of complex scientific data to diverse audiences, including healthcare professionals and patients, thereby supporting evidence-based decision-making. Moreover, as the demand for clear and reliable medical information grows—driven by an increasing volume of clinical trials and research studies—companies that invest in proficient medical writing can enhance their credibility and market presence. This ultimately leads to improved patient care and better health outcomes.
Medical Writing Market Dynamics
The medical writingmarket is expected to witness significant growth in the future due to the increasing volume of clinical trials and research studies, stringent regulatory requirements for drug approval and labeling, and growing emphasis on evidence-based medicine. However, the high competition within the medical writing industry, evolving regulatory guidelines requiring continuous updates, and budget constraints limiting outsourcing for smaller companies are restraining the growth of the market.
Furthermore, growing demand for regulatory writing services, increased outsourcing of medical writing by pharmaceutical companies, and expansion into emerging markets with favorable clinical trial environments are the key trends propelling the medical writing market.
Increasing Volume of Clinical Trials and Research Studies is Driving the Medical Writing Market
The increasing volume of clinical trials and research studies is significantly impacting the medical writing market by driving demand for skilled medical writers and comprehensive documentation.
• For instance, the FDA noted a 6% increase in Investigational New Drug (IND) applications in fiscal year 2022, which further emphasizes the need for precise documentation to support these applications.
• Companies like Parexel are actively hiring medical writers to meet these needs, highlighting the critical role that medical writing plays in facilitating successful clinical trials and regulatory compliance.
Additionally, initiatives such as the rapid development of COVID-19 vaccines showcased how efficient medical writing can accelerate the approval process and enhance public health outcomes. This synergy between rising clinical research activities and the need for expert medical writing underscores a growing market opportunity for companies specializing in this field.
By Type, the Regulatory Writing Segment is projected to be the Largest Segment in the Medical Writing Market
Regulatory writing is the largest segment in the medical writingmarket, driven by the increasing complexity of drug approvals and the rising number of clinical trials.
• For instance, companies like IQVIA and Parexel are expanding their regulatory writing services to accommodate the growing demand; IQVIA reported handling over 2,500 regulatory documents annually as of 2022.
• In June 2021, Certara, Inc. acquired Insight Medical Writing, enhancing its regulatory science capabilities across Europe and the UK, reflecting strategic moves by companies to bolster their offerings in this area.
Additionally, the favorable environment for clinical trials in emerging markets, coupled with new medical device regulations, is further driving the need for specialized regulatory writing services.
• As reported in March 2021, there were approximately 373,420 research studies registered globally, underscoring the substantial demand for accurate and compliant documentation throughout the drug development process.
This trend highlights how regulatory writing is becoming increasingly vital for companies navigating complex approval pathways in a rapidly evolving healthcare landscape.
By Geography, North America Holds the Largest Share in the Market Revenue
North America holds the largest share of the medical writingmarket, driven by the region's robust pharmaceutical and biotechnology sectors, which are characterized by a high volume of clinical trials and stringent regulatory requirements.
• As of July 2024, ClinicalTrials.gov reported over 450,000 registered studies, with many based in the United States, highlighting the substantial need for comprehensive medical documentation.
• In 2023 alone, the FDA approved 55 innovative medications, necessitating extensive regulatory submissions and clinical trial reports, which are critical components of medical writing.
The Pharmaceutical Research and Manufacturers of America (PhRMA) indicated that the U.S. biopharmaceutical industry directly employs over 800,000 people, further emphasizing the industry's scale and its reliance on effective medical writing services.
• Additionally, in 2020, government initiatives such as the National Institutes of Health's funding for clinical research, which reached approximately $17.6 billion, underscore the commitment to advancing healthcare through rigorous research efforts that require meticulous documentation.
Overall, the combination of an expanding clinical trial landscape, high regulatory standards, and significant investment in research and development positions North America as a critical hub for medical writing services.
Key Target Audience:
• Pharmaceutical Companies
• Contract Research Organizations (CROs)
• Medical Device Companies
• Healthcare Professionals
• Regulatory Authorities
• Investors and Venture Capitalists
List of the Key Players Profiled in the Report Includes:
• Parexel International Corporation
• IQVIA
• SIRO CLIN PHARM
• Clinical Life Sciences Pvt
• OMICS International
• Freyr Solutions
• Cactus Communications
• Covance Inc
• SYNCHROGENIX
• INCLINE
Recent Developments:
• In June 2025, IQVIA launched AI-powered agents (in partnership with NVIDIA) to improve clinical data review, literature aggregation, and site engagement—integrated into its broader tech-enabled writing solutions.
• In September 2024, Parexel strengthens its real-world research capabilities by appointing a new senior vice president, enhancing its offerings in clinical development and patient engagement.
Market Segmentation:
The research report includes in-depth coverage of the industry analysis with size, share, and forecast for the below segments:
Market by, Type:
• Medical Writing
• Scientific Writing
• Regulatory Writing
• Clinical Writing
• Type Writing
• Other Types
Market by, Application:
• Medical Education
• Medical Journalism
• Medico Marketing
• Other Applications
Market by, End-User:
• Medical Device/Pharmaceutical & Biotechnology Companies
• Contract Research Organizations (CROs)
• Other End-Users
Market by, Geography:
The medical writingmarket report also analyzes the major geographic regions and countries of the market. The regions and countries covered in the study include:
• North America (The United States, Canada, Mexico), Market Estimates, Forecast & Opportunity Analysis
• Europe (Germany, France, UK, Italy, Spain, Rest of Europe), Market Estimates, Forecast & Opportunity Analysis
• Asia Pacific (China, Japan, India, South Korea, Australia, New Zealand, Rest of Asia Pacific), Market Estimates, Forecast & Opportunity Analysis
• South America (Brazil, Argentina, Chile, Rest of South America), Market Estimates, Forecast & Opportunity Analysis
• Middle East & Africa (UAE, Saudi Arabia, Qatar, Iran, South Africa, Rest of Middle East & Africa), Market Estimates, Forecast & Opportunity Analysis
The report offers insights into the following aspects:
• Analysis of major market trends, factors driving, restraining, threatening, and providing opportunities for the market.
• Analysis of the market structure by identifying various segments and sub-segments of the market.
• Understand the revenue forecast of the market for North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
• Analysis of opportunities by identification of high-growth segments/revenue pockets in the market.
• Understand major player profiles in the market and analyze their business strategies.
• Understand competitive developments such as joint ventures, alliances, mergers and acquisitions, and new product launches in the market.
Table Of Content
1 Market Introduction
1.1 Market Definition
1.2 Research Scope and Segmentation
1.3 Stakeholders
1.4 List of Abbreviations
2 Executive Summary
3 Research Methodology
3.1 Identification of Data
3.2 Data Analysis
3.3 Verification
3.4 Data Sources
3.5 Assumptions
4 Market Dynamics
4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Market Challenges
5 Porter's Five Force Analysis
5.1 Bargaining Power of Suppliers
5.2 Bargaining Power of Buyers
5.3 Threat of New Entrants
5.4 Threat of Substitutes
5.5 Competitive Rivalry in the Market
6 Global Medical Writing Market by, Type
6.1 Overview
6.2 Medical Writing
6.3 Scientific Writing
6.4 Regulatory Writing
6.5 Clinical Writing
6.6 Type Writing
6.7 Other Types
7 Global Medical Writing Market by, Application
7.1 Overview
7.2 Medical Education
7.3 Medical Journalism
7.4 Medico Marketing
7.5 Other Applications
8 Global Medical Writing Market by, End-User
8.1 Overview
8.2 Medical Device/Pharmaceutical & Biotechnology Companies
8.3 Contract Research Organizations (CROs)
8.4 Other End-Users
9 Global Medical Writing Market by, Geography
9.1 Overview
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 UK
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 South Korea
9.4.5 Australia
9.4.6 New Zealand
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 UAE
9.6.2 Saudi Arabia
9.6.3 Qatar
9.6.4 Iran
9.6.5 South Africa
9.6.6 Rest of Middle East & Africa
10 Key Developments
11 Company Profiling
11.1 Parexel International Corporation
11.1.1 Business Overview
11.1.2 Product/Service Offering
11.1.3 Financial Overview
11.1.4 SWOT Analysis
11.1.5 Key Activities
11.2 IQVIA
11.3 SIRO CLIN PHARM
11.4 Clinical Life Sciences Pvt
11.5 OMICS International
11.6 Freyr Solutions
11.7 Cactus Communications
11.8 Covance Inc
11.9 SYNCHROGENIX
11.10 INCLINE
Report Details
SKU Code | : DI2613 |
Industry | : Healthcare |
Region | : Global |
Tables | : 96 |
Format | : Electronic PDF |
Published | : 2025 |
Choose License Type
Why Diligence Insights?
-
24/7 Research Support
We understand the various needs of our customers and remain always flexible in our approach. And we have a 24X7 client engagement team to ensure the best customer experience.
-
Tailor-Made Values
We consider each and every client’s business issues unique and exhibit precise solutions befitting your business goals and expectations.
-
Data Accuracy and Reliability
We offer a 360-degree view of the market to generate high standards and comprehensive data.
-
Customer Satisfaction
At Diligence Insights, we are committed to offering high-quality market research reports to our esteemed clients and focus on providing innovative solutions.
-
Information Security
We stand by the information security policy and stick to keeping your business information safe and secure.